TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 36429945

Group type: EXPERIMENTAL
Intervention: New auditory feedback device for basic hands-on CPR training
Number of subjects: 100
Study: 34712679

Group type: EXPERIMENTAL
Intervention: Jinhua Qinggan granules combined with antiviral drugs
Number of subjects: 123

Group type: COMPARATOR
Intervention: Antiviral drugs alone (Western medicine group)
Number of subjects: 123
Study: 32678782

Group type: EXPERIMENTAL
Intervention: 3-D cube task at near distance (0.3 m)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 3-D cube task at middle distance (0.6 m)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Web-browsing task with medium window size (default: 1.0 × 1.1 m)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 3-D cube and web-browsing tasks at near distance or large window size
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: AR interactions with far target distance
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Near to middle distance (less than 0.6 m) or medium to large window size (greater than 1.0 × 1.1 m)
Number of subjects: 20
Study: 34041634

Group type: EXPERIMENTAL
Intervention: sugammadex (2mg/kg)
Number of subjects: 38

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 38
Study: 33556963

Group type: EXPERIMENTAL
Intervention: Systolic Blood Pressure (SBP)
Number of subjects: 1000000

Group type: EXPERIMENTAL
Intervention: Diastolic Blood Pressure (DBP)
Number of subjects: 1000000

Group type: EXPERIMENTAL
Intervention: Pulse Pressure (PP)
Number of subjects: 1000000
Study: 34617398

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0

Group type: COMPARATOR
Intervention: iGlar
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lixi
Number of subjects: 0
Study: 34726653

Group type: EXPERIMENTAL
Intervention: Single-family room (SFR)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Open-bay (OB)
Number of subjects: 71
Study: 32094442

Group type: EXPERIMENTAL
Intervention: Functional somatic syndromes (FSS)
Number of subjects: 1590

Group type: EXPERIMENTAL
Intervention: Irritable bowel syndrome
Number of subjects: 1590

Group type: EXPERIMENTAL
Intervention: Chronic widespread pain
Number of subjects: 1590

Group type: EXPERIMENTAL
Intervention: Chronic fatigue
Number of subjects: 1590

Group type: EXPERIMENTAL
Intervention: Whiplash associated disorders
Number of subjects: 1590

Group type: EXPERIMENTAL
Intervention: Multiple chemical sensitivity
Number of subjects: 1590

Group type: EXPERIMENTAL
Intervention: Bodily distress syndrome (BDS)
Number of subjects: 1590

Group type: EXPERIMENTAL
Intervention: Diagnostic agreement of FSS and BDS
Number of subjects: 1590

Group type: EXPERIMENTAL
Intervention: Multi-syndromatic FSS and multi-organ BDS
Number of subjects: 1590
Study: 34475191

Group type: EXPERIMENTAL
Intervention: LetSync mobile health app intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: Waitlist-control arm
Number of subjects: 160
Study: 32017923

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 151

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 151
Study: 34515113

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 169

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 169
Study: 34370610

Group type: EXPERIMENTAL
Intervention: TSTM (The Secret Trail of Moon) VR serious videogame
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Online chess training (therapeutic chess)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 105
Study: 36013168

Group type: EXPERIMENTAL
Intervention: Lung ultrasound-guided therapy (LUS)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: LUS
Number of subjects: 79

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 79
Study: 33151350

Group type: EXPERIMENTAL
Intervention: Experimental group (attention to tactile stimuli)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (attention to a video game)
Number of subjects: 80
Study: 34702772

Group type: EXPERIMENTAL
Intervention: Low pretreatment ctDNA
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Early increase in ctDNA at week 2 compared with baseline
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: ctDNA counts or clearance at week 4 or 7
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Pretreatment ctDNA values
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: ctDNA values at week 2
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: ctDNA and imaging metrics
Number of subjects: 34
Study: 34833411

Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspirate Concentrate (BMAC)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma (PRP)
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA)
Number of subjects: 175
Study: 36086764

Group type: EXPERIMENTAL
Intervention: Remifentanil 1.0 ng/mL with midazolam
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Remifentanil 2.0 ng/mL with midazolam
Number of subjects: 80
Study: 33878132

Group type: EXPERIMENTAL
Intervention: Nomophobia Questionnaire (NMP-Q)
Number of subjects: 2260

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 2260

Group type: EXPERIMENTAL
Intervention: Anxiety
Number of subjects: 2260

Group type: EXPERIMENTAL
Intervention: Insomnia
Number of subjects: 2260
Study: 35476651

Group type: EXPERIMENTAL
Intervention: Nasal high-flow therapy
Number of subjects: 202

Group type: COMPARATOR
Intervention: Standard care (no nasal high-flow therapy or supplemental oxygen)
Number of subjects: 202
Study: 34886454

Group type: EXPERIMENTAL
Intervention: Multidimensional Temperance Scale
Number of subjects: 860
Study: 32773834

Group type: EXPERIMENTAL
Intervention: Paper-based cases
Number of subjects: 27

Group type: COMPARATOR
Intervention: Virtual patient cases
Number of subjects: 27
Study: 36242928

Group type: EXPERIMENTAL
Intervention: HFNC plus five 30-minute physiotherapy-led NIV sessions
Number of subjects: 130

Group type: COMPARATOR
Intervention: Continuous HFNC for 48-hours following surgical extubation
Number of subjects: 130
Study: 33368963

Group type: COMPARATOR
Intervention: 800 IU vitamin D3
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: 2000 IU vitamin D3
Number of subjects: 251
Study: 34568236

Group type: EXPERIMENTAL
Intervention: Bifidobacterium longum CECT7894 and Pediococcus pentosaceus CECT8330 (1 × 10^9 CFU)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 33909090

Group type: EXPERIMENTAL
Intervention: Texture analysis based on unenhanced CT (UECT)
Number of subjects: 104
Study: 32008947

Group type: EXPERIMENTAL
Intervention: Ambrisentan
Number of subjects: 31
Study: 33181560

Group type: EXPERIMENTAL
Intervention: High-Flow Nasal Cannula (HFNC) with a flow rate of 2 L kg‐1 min‐1
Number of subjects: 78

Group type: COMPARATOR
Intervention: Conventional oxygen therapy (Control)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups (HFNC and Control)
Number of subjects: 78
Study: 32170769

Group type: EXPERIMENTAL
Intervention: Bortezomib consolidation (BC) - 1.3 mg/m2 IV days 1, 4, 8, 11 of a 3-week cycle for four cycles
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Bortezomib maintenance (BM) - 1.6 mg/m2 IV once weekly × 4 every 8 weeks for 18 months
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group from CALGB/Alliance 59909
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: MRD-negative post-induction
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: High risk proliferation signature
Number of subjects: 151
Study: 35344520

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 626
Study: 33671257

Group type: EXPERIMENTAL
Intervention: WNV infection
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Cytokine profiles
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: WNV participants with CKD
Number of subjects: 89
Study: 32568897

Group type: EXPERIMENTAL
Intervention: Computer-based tutor
Number of subjects: 0

Group type: COMPARATOR
Intervention: Textbook learning
Number of subjects: 0
Study: 35100614

Group type: EXPERIMENTAL
Intervention: Adenosine triphosphate (ATP) monitoring
Number of subjects: 6

Group type: COMPARATOR
Intervention: Ultraviolet fluorescent marker (UV/F)
Number of subjects: 6
Study: 33466606

Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mechanical Vibration (MV)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Percussion Therapy (PT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Foam Roller (FR)
Number of subjects: 40
Study: 34698558

Group type: EXPERIMENTAL
Intervention: PDT+PBM‐T
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: PDT+PBM‐T+ILIB
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: ILIB
Number of subjects: 36
Study: 33471581

Group type: EXPERIMENTAL
Intervention: Antecedent-based techniques (stimulus control)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Consequent-based techniques (contingency management)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control condition (waitlist)
Number of subjects: 90
Study: 35511887

Group type: EXPERIMENTAL
Intervention: Arm-crank exercise training (ACT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Walking training (WT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 45
Study: 32823974

Group type: EXPERIMENTAL
Intervention: Multivitamin and mineral supplement (Redoxon® VI, Singapore) taken daily for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo control (inactive) taken daily for 12 weeks
Number of subjects: 0
Study: 35427519

Group type: EXPERIMENTAL
Intervention: Management of uncomplicated acute malnutrition
Number of subjects: 234

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 234
Study: 32255250

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided stellate ganglion blockades (us-SGBs)
Number of subjects: 105
Study: 32719525

Group type: EXPERIMENTAL
Intervention: 0.02% polyhexamethylene biguanide (PHMB) and 0.02% chlorhexidine (BG)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 1% voriconazole (VZ)
Number of subjects: 23
Study: 32979077

Group type: EXPERIMENTAL
Intervention: 300 mg/d DHA for 6 months
Number of subjects: 106

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 106
Study: 32532761

Group type: EXPERIMENTAL
Intervention: Micropulse laser therapy (MLT)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Photodynamic therapy (PDT)
Number of subjects: 33
Study: 36279159

Group type: EXPERIMENTAL
Intervention: Smartphone app group
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 109
Study: 33444588

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/d)
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Placebo Vitamin D
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: Marine n-3 fatty acid (1 g/d)
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Placebo n-3 fatty acid
Number of subjects: 1032
Study: 34762734

Group type: EXPERIMENTAL
Intervention: GA intervention
Number of subjects: 541

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 541
Study: 33413588

Group type: EXPERIMENTAL
Intervention: Tocilizumab (TCZ) 8 mg/kg
Number of subjects: 387

Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX) 7.5-20 mg/kg
Number of subjects: 387

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 387
Study: 35533220

Group type: EXPERIMENTAL
Intervention: Text message-delivered cardiac education and support
Number of subjects: 1424

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 1424
Study: 32994063

Group type: EXPERIMENTAL
Intervention: Mini Percutaneous Nephrolithotomy (mPNL)
Number of subjects: 1980

Group type: COMPARATOR
Intervention: Standard Percutaneous Nephrolithotomy (sPNL)
Number of subjects: 1980
Study: 33212231

Group type: EXPERIMENTAL
Intervention: PMDI (ropivacaine, epinephrine, ketoprofen)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control (no injection)
Number of subjects: 59
Study: 32096595

Group type: EXPERIMENTAL
Intervention: MTA
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Biodentine
Number of subjects: 50
Study: 34345168

Group type: EXPERIMENTAL
Intervention: Multicomponent intervention targeting caregivers (14 psychoeducational group sessions over 5 days)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 142
Study: 35763974

Group type: EXPERIMENTAL
Intervention: High groove music during rhythmic auditory stimulation (RAS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Synchronized walking with high groove music
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unfamiliar stimuli while walking
Number of subjects: 0
Study: 33683325

Group type: EXPERIMENTAL
Intervention: 5 days of high-dose amoxicillin followed by 5 days of placebo
Number of subjects: 281

Group type: COMPARATOR
Intervention: 5 days of high-dose amoxicillin followed by a different formulation of 5 days of high-dose amoxicillin
Number of subjects: 281
Study: 32388274

Group type: EXPERIMENTAL
Intervention: 400 g of cod fillets per week
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control (continued habitual diet)
Number of subjects: 137
Study: 35170539

Group type: EXPERIMENTAL
Intervention: Adjuvant steroid therapy (10-12 weeks)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (routine postoperative treatment)
Number of subjects: 200
Study: 35157646

Group type: EXPERIMENTAL
Intervention: Virtual reality training (Group A)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Task-oriented training (Group B)
Number of subjects: 52
Study: 32575480

Group type: EXPERIMENTAL
Intervention: Pain Bloc-R
Number of subjects: 27

Group type: COMPARATOR
Intervention: Acetaminophen
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 34407034

Group type: EXPERIMENTAL
Intervention: Interactive virtual walking intervention
Number of subjects: 27

Group type: COMPARATOR
Intervention: Passive, noninteractive virtual walking condition (control)
Number of subjects: 27
Study: 34798060

Group type: EXPERIMENTAL
Intervention: Cagrilintide 0.3-4.5 mg
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: Cagrilintide 4.5 mg
Number of subjects: 706

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 706
Study: 34129074

Group type: EXPERIMENTAL
Intervention: Self-adhesive bulk-fill restorative (SABF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional bulk-fill composite (FOBF)
Number of subjects: 30
Study: 34233667

Group type: EXPERIMENTAL
Intervention: CMT positive milk samples
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: S. aureus isolates
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: MRSA identification
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Overall MRSA prevalence
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Antibiotic sensitivity to Cefazolin
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Antibiotic sensitivity to Tetracycline
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Resistance to Ampicillin
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Multidrug resistance
Number of subjects: 460
Study: 35027029

Group type: EXPERIMENTAL
Intervention: Telehealth-delivered anti-inflammatory dietary education intervention (9-week duration, 1:1 consultations at baseline, 3- and 6-week follow-up).
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Telehealth-delivered anti-inflammatory dietary education intervention.
Number of subjects: 28
Study: 32052313

Group type: EXPERIMENTAL
Intervention: DRL_RI
Number of subjects: 276

Group type: COMPARATOR
Intervention: RTX-US
Number of subjects: 276
Study: 35194918

Group type: EXPERIMENTAL
Intervention: Local anal anaesthetic
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 34628376

Group type: EXPERIMENTAL
Intervention: Nano-ceramic photocomposite
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microhybrid photocomposite
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Microfilled photocomposite
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nanofilled photocomposite
Number of subjects: 0
Study: 35388666

Group type: EXPERIMENTAL
Intervention: Oral tebipenem pivoxil hydrobromide (600 mg every 8 hours)
Number of subjects: 1372

Group type: COMPARATOR
Intervention: Intravenous ertapenem (1 g every 24 hours)
Number of subjects: 1372

Group type: EXPERIMENTAL
Intervention: Oral tebipenem pivoxil hydrobromide
Number of subjects: 1372

Group type: COMPARATOR
Intervention: Intravenous ertapenem
Number of subjects: 1372
Study: 32567438

Group type: EXPERIMENTAL
Intervention: Intermittent vascular occlusion (IVO)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 12
Study: 32303206

Group type: EXPERIMENTAL
Intervention: Test toothpaste (sodium fluoride toothpaste containing lactate ion and polyvinylmethylether‐maleic anhydride)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Reference toothpaste (stannous fluoride‐zinc citrate, SnF2‐Zn)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo toothpaste (fluoride-free)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Test toothpaste
Number of subjects: 62
Study: 35220995

Group type: EXPERIMENTAL
Intervention: Exercise group (structured exercise programme with physiotherapy, 3-6 appointments)
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 392

Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 392
Study: 33188693

Group type: EXPERIMENTAL
Intervention: Vadadustat
Number of subjects: 3923

Group type: COMPARATOR
Intervention: Darbepoetin alfa (ESA)
Number of subjects: 3923
Study: 32805198

Group type: EXPERIMENTAL
Intervention: Genetic risk score for systolic blood pressure (GRSSBP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic risk score for diastolic blood pressure (GRSDBP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic risk score for mean arterial pressure (GRSMAP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic risk score for pulse pressure (GRSPP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetic risk score for hypertension (GRSHTN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined genetic risk score (GRScomb)
Number of subjects: 0
Study: 36145064

Group type: EXPERIMENTAL
Intervention: Fava bean protein (FBP) 0.33 g·kg‐1
Number of subjects: 16

Group type: COMPARATOR
Intervention: Negative control (EAA‐free mixture)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Resistance exercise
Number of subjects: 16
Study: 34407776

Group type: EXPERIMENTAL
Intervention: Computer-assisted navigation (CAS) TKA
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional TKA
Number of subjects: 50
Study: 32424935

Group type: EXPERIMENTAL
Intervention: 1.8 mg/d liraglutide
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 33319249

Group type: EXPERIMENTAL
Intervention: TAK-003
Number of subjects: 20099
Study: 34473788

Group type: EXPERIMENTAL
Intervention: VPI with MI tasks (combined condition)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: MI condition
Number of subjects: 20

Group type: COMPARATOR
Intervention: VPI condition
Number of subjects: 20
Study: 34438364

Group type: EXPERIMENTAL
Intervention: Blood flow restriction (BFR) resistance training
Number of subjects: 4

Group type: COMPARATOR
Intervention: High- or low-load resistance training
Number of subjects: 4
Study: 34053489

Group type: EXPERIMENTAL
Intervention: ICP+PbtO2 monitoring group
Number of subjects: 70

Group type: COMPARATOR
Intervention: ICP monitoring group
Number of subjects: 70
Study: 35640182

Group type: EXPERIMENTAL
Intervention: Functional non-removable orthodontic device (FNT)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Combined orthodonto-surgical treatment
Number of subjects: 83

Group type: COMPARATOR
Intervention: Removal of individual teeth and retraction of front teeth
Number of subjects: 83
Study: 34097759

Group type: EXPERIMENTAL
Intervention: Low-pressure pneumoperitoneum (10 mm Hg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standard-pressure pneumoperitoneum (14 mm Hg)
Number of subjects: 80
Study: 32579811

Group type: EXPERIMENTAL
Intervention: Allopurinol (100 to 300 mg daily)
Number of subjects: 369

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 369
Study: 35506425

Group type: EXPERIMENTAL
Intervention: Brief Information Pack (BIP)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Extra time with alcohol and drug nurses
Number of subjects: 31
Study: 33863276

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia (CBT-i)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 32
Study: 36333742

Group type: EXPERIMENTAL
Intervention: music therapy activities
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: community music
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: family concerts
Number of subjects: 40

Group type: COMPARATOR
Intervention: control group
Number of subjects: 40
Study: 32722424

Group type: EXPERIMENTAL
Intervention: Choline bitartrate
Number of subjects: 37

Group type: COMPARATOR
Intervention: No choline control
Number of subjects: 37

Group type: COMPARATOR
Intervention: Phosphatidylcholine
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Gut microbiota composition
Number of subjects: 37
Study: 33906105

Group type: EXPERIMENTAL
Intervention: ROSE trial participation recall
Number of subjects: 487

Group type: COMPARATOR
Intervention: Study participation recall
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: 6-month attrition among recalled participants
Number of subjects: 487

Group type: COMPARATOR
Intervention: 6-month attrition among non-recalled participants
Number of subjects: 487

Group type: EXPERIMENTAL
Intervention: Reconsent and recall
Number of subjects: 487
Study: 32069071

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (PRO)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 35545225

Group type: EXPERIMENTAL
Intervention: Rapid Intermittent Bolus (RIB) of electrolyte-free solution for 1 hour
Number of subjects: 166

Group type: COMPARATOR
Intervention: Slow Continuous Infusion (SCI) of electrolyte-free solution continuously
Number of subjects: 166
Study: 32087113

Group type: EXPERIMENTAL
Intervention: Contact isolation alongside standard precautions for 12 months
Number of subjects: 15

Group type: COMPARATOR
Intervention: Standard precautions alone for 12 months
Number of subjects: 15